Shuli Wei Mangsha Hu Yan Yang Xiaojie Huang Baizhou Li Liren Ding Pingli Wang
10.3389/fonc.2022.862008
Front Oncol
2022 Apr 28;12:862008.
ros1 ceritinib crizotinib non-small cell lung cancer (nsclc) translocated promoter region (tpr)
CC BY
https://pubmed.ncbi.nlm.nih.gov/35574423/
Case Reports
PMC9096128
35574423
Case Report: Short-Term Response to First-Line Crizotinib Monotherapy in a Metastatic Lung Adenocarcinoma Patient Harboring a Novel TPR-ROS1 Fusion
2022